Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03460158 · ClinicalTrials.gov registry record · Phase 4
Prospective Evaluation of Facial Cosmetic Procedures
A Phase 4 study of Cosmetic Techniques, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT03460158: Completed Phase 4 study of Cosmetic Techniques, sponsored by University of Pennsylvania.
NCT03460158 is a Phase 4 study of Cosmetic Techniques that has completed, run by University of Pennsylvania. The registered enrollment target is 101 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03460158, a Phase 4 study of Cosmetic Techniques, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, trial to quantitatively and qualitatively compare the dermal fillers for the treatment of age related aesthetic changes.
Primary Outcome
Absolute Change of the Patient Satisfaction using the validated FACE-Q Aesthetics questionnaire for patient reported assessment of treatment by domain. The absolute change from the patient reported outcome score prior to injection to the patient reported score immediate post-injection. Increase in numeric value indicates the larger patient reported improvement, except for psychosocial distress module where a decrease in numeric value indicates patient improvement. Maximum change 99 and Minimum
Conditions Studied
Interventions
- DRUG Restylane-L®
- DRUG Restylane-L® Lyft
- DRUG Restylane Silk®
Study Locations (1)
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-08-21 |
| Est. Completion | 2024-05-29 |
| Phase | Phase 4 |
What the finished NCT03460158 record still lists
NCT03460158 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Cosmetic Techniques appearing as the primary indexed condition, and to 3 interventions - of which Restylane-L® is the first listed.
NCT03460158 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03460158 about?
NCT03460158 is a clinical study titled "Prospective Evaluation of Facial Cosmetic Procedures". A prospective, trial to quantitatively and qualitatively compare the dermal fillers for the treatment of age related aesthetic changes.
What is the current status of trial NCT03460158?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2020-08-21. Estimated completion is 2024-05-29.
What conditions does trial NCT03460158 study?
This clinical trial studies the following conditions: Cosmetic Techniques.
What interventions are being tested in trial NCT03460158?
The interventions under investigation include: Restylane-L® (DRUG), Restylane-L® Lyft (DRUG), Restylane Silk® (DRUG).
Who is sponsoring clinical trial NCT03460158?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03460158 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03460158's enrollment target sits among peer trials
101 766th of 2000 higher than 1,232 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI